FactaeThe Factual News

Innate Pharma plummets after PACIFIC-9 trial failure for oleclumab

Innate Pharma's PACIFIC-9 clinical trial for oleclumab has failed.

Published 6h1 sourceNotableupdated 4h

Lire en français

≈ 15sSpeed

The fact

The treatment for non-small cell lung cancer shows insufficient efficacy.

The French biopharmaceutical company's stock plunges on the market.

Click the link to read an article on the topic:

Explore this topic

Sonia Quaratino Innate Pharma #Innate Pharma #essai clinique #oléclumab #cancer #biotechnologies #marchés financiers #bourse #échec thérapeutique

What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.

FranceWorld map →

Follow topic →

Auto-synthesis from 1 media source · identified on September 1, 2026

← Back to home

Discover

Read more

All marches →